FibroBiologics, Inc. Common Stock
FBLG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $65,750 | $945,519 | $945,519 | $945,519 |
| - Cash | $13,985 | $9,163 | $2,266 | $407 |
| + Debt | $10,553 | $1,747 | $7,524 | $1,525 |
| Enterprise Value | $62,318 | $938,103 | $950,777 | $946,637 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$10,568 | -$15,901 | -$4,373 | -$1,578 |
| % Margin | – | – | – | – |
| Net Income | -$11,161 | -$16,485 | -$5,121 | -$1,582 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.34 | -0.59 | -0.16 | -0.049 |
| % Growth | 42.4% | -268.7% | -228.5% | – |
| Operating Cash Flow | -$11,901 | -$6,401 | -$4,066 | -$1,410 |
| Capital Expenditures | -$184 | -$495 | $0 | $0 |
| Free Cash Flow | -$12,085 | -$6,896 | -$4,066 | -$1,410 |